Prostate cancer kills more than 12,000 men a year in the UK, slightly more than the number of women who die from breast ...
March 15, 2026 expert reaction to conference abstract comparing prostate cancer and breast cancer screening programmes, being presented at the European Association of Urology Cong ...
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation by Dr. Laurence Klotz discussing initial perioperative outcomes of CAPTAIN, ...
The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...
Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
First results of the PRIMARY2 randomized phase III trial support consideration of PSMA PET/CT in diagnostic work-up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results